Gapping up
In reaction to earnings/guidance:
- GOOS +9.4%, BJ +4.7%, SQM +4.6%, SNPS +3.9%, WMS +2.9%, GDS +1.6%, CPRT +1.4%, WNC +1.4% (longer term guidance), HWKN +0.9%, MNRO +0.8%
Other news:
- RCKT +10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy)
- SIGA +6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for the treatment of smallpox)
- KOD +5.3% (Baker Brothers affirms increased active stake following recent purchase ~457K shares (5/16-5/18 transaction dates))
- MRSN +4.9% (granted orphan drug designation to XMT-2056)
- KBR +3.5% (awarded two task orders under the Department of Defense Information Analysis Center's multiple-award contract vehicle totaling $106 mln for the Air Force Life Cycle Management Cente)
- CDEV +2.9% (Centennial Resource Development and Colgate Energy Partners III to combine in merger of equals)
- DMTK +1.8% (presents new research differentiating atopic dermatitis and psoriasis)
- AUR +1.7% (AUR expands autonomous commercial linehaul trucking pilot with FDX)
- FYBR +1.7% (updates shareholders at MoffettNathanson Conference; plans to exceed fiber build target in 2022)
- CURO +1.4% (agrees to sell legacy U.S. direct lending business for $345 mln; acquires First Heritage Credit for $140 mln)
- KDNY +1.3% (Presents Updated Data from BION-1301 Phase 1/2 Trial)
- HSTM +1.1% (acquires CloudCME)